An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet-Reference-Cited by-同舟云学术

An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet

Published:2020-09-13 Issue:8 Volume:50 Page:685-706
ISSN:1040-8444
Container-title:Critical Reviews in Toxicology
language:en
Short-container-title:Critical Reviews in Toxicology

Author:

Bhat Virunya S.¹^ORCID,Cohen Samuel M.²^ORCID,Gordon Elliot B.³,Wood Charles E.⁴,Cullen John M.⁵⁶,Harris Mark A.⁷^ORCID,Proctor Deborah M.⁸^ORCID,Thompson Chad M.⁷^ORCID

Affiliation:

1. ToxStrategies, Inc., Hudson, MA, USA

2. Havlik-Wall Professor of Oncology, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA

3. Elliot Gordon Consulting, LLC, Princeton Junction, NJ, USA

4. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA

5. North Carolina State University, Raleigh, NC, USA

6. EPL, Inc., Sterling, VA, USA

7. ToxStrategies, Inc., Katy, TX, USA

8. ToxStrategies, Inc., Mission Viejo, CA, USA

Publisher

Informa UK Limited

Subject